NCT00441168 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 29
- units
- Participants
- groups
- description
- vincristine: 0.4mg IV push on days 1 to 4; adriamycin: 9mg/m² IV push on days 1 to 4; dexamethasone: 40 mg daily days 1- 4/9-12/17-20 - cycle 1 / days 1-4/17-20 - subsequent cycle
- id
- BG000
- title
- VAD Treatment
- description
- bortezomib: 1.3 mg/m² intravenous (IV) bolus on days 1, 4, 8, and 11; adriamycin: 9mg/m² IV push on days 1 to 4; dexamethasone: 40 mg daily days 1- 4/9-12/17-20 - cycle 1 / days 1-4/17-20 - subsequent cycle
- id
- BG001
- title
- PAD Treatment
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.4
- value
- 64.0
- group Id
- BG001
- spread
- 11.3
- value
- 61.5
- group Id
- BG002
- spread
- 10.2
- value
- 62.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- title
- Female
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 21
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 29
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- ≤50
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- 60
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- 70
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 12
- title
- 80
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- title
- 90
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- title
- 100
- description
- A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient's ability to function, or to decide if a patient could be included in a clinical trial.
- param Type
- NUMBER
- title
- Karnofsky Performance Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.233
- value
- 1.855
- group Id
- BG001
- spread
- 0.219
- value
- 1.924
- group Id
- BG002
- spread
- 0.226
- value
- 1.886
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Surface Area
- unit Of Measure
- m2
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.2
- value
- 168.8
- group Id
- BG001
- spread
- 9.5
- value
- 169.8
- group Id
- BG002
- spread
- 10.3
- value
- 169.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.7
- value
- 75.9
- group Id
- BG001
- spread
- 14.5
- value
- 78.3
- group Id
- BG002
- spread
- 15.0
- value
- 77.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 29
- units
- Participants
- groups
- description
- vincristine: 0.4mg IV push on days 1 to 4; adriamycin: 9mg/m² IV push on days 1 to 4; dexamethasone: 40 mg daily days 1- 4/9-12/17-20 - cycle 1 / days 1-4/17-20 - subsequent cycle
- id
- BG000
- title
- VAD Treatment
- description
- bortezomib: 1.3 mg/m² intravenous (IV) bolus on days 1, 4, 8, and 11; adriamycin: 9mg/m² IV push on days 1 to 4; dexamethasone: 40 mg daily days 1- 4/9-12/17-20 - cycle 1 / days 1-4/17-20 - subsequent cycle
- id
- BG001
- title
- PAD Treatment
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.4
- value
- 64.0
- group Id
- BG001
- spread
- 11.3
- value
- 61.5
- group Id
- BG002
- spread
- 10.2
- value
- 62.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- title
- Female
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 21
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 29
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- ≤50
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 2
- title
- 60
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- 70
- categories
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 12
- title
- 80
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 8
- title
- 90
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 3
- title
- 100
- description
- A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance Scores (KPS) range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient's ability to function, or to decide if a patient could be included in a clinical trial.
- param Type
- NUMBER
- title
- Karnofsky Performance Status
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 0.233
- value
- 1.855
- group Id
- BG001
- spread
- 0.219
- value
- 1.924
- group Id
- BG002
- spread
- 0.226
- value
- 1.886
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body Surface Area
- unit Of Measure
- m2
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.2
- value
- 168.8
- group Id
- BG001
- spread
- 9.5
- value
- 169.8
- group Id
- BG002
- spread
- 10.3
- value
- 169.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.7
- value
- 75.9
- group Id
- BG001
- spread
- 14.5
- value
- 78.3
- group Id
- BG002
- spread
- 15.0
- value
- 77.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle